OLUMIANT -
Alopecia Areata
USA - Europe - Asia CAMPAIGN
Health Care Providers (HCP)
Client:
Eli Lilly US
—
CD: Shawn Taylor - Chris Paleczny
ACD/Art: Ekaterina Goldberg
ACD/Copy: Frank Gillam
Copy Supervisor: Eugene Park
Art Director/Graphic Designer: Manuel Benitez
—
Agency:
GREY New York - Toronto
Eli Lilly US
—
CD: Shawn Taylor - Chris Paleczny
ACD/Art: Ekaterina Goldberg
ACD/Copy: Frank Gillam
Copy Supervisor: Eugene Park
Art Director/Graphic Designer: Manuel Benitez
—
Agency:
GREY New York - Toronto
Challenge:
Alopecia Areata, a surprisingly common condition, touches the lives of approximately 2% of individuals worldwide. Whether facing it, overcoming it, or poised to encounter it, a significant global community grapples with Alopecia Areata. In the United States, an astounding 6.7 million people are affected by this condition. Join the movement to raise awareness and support those affected by participating in the first campaign for the only FDA-approved treatment for Alopecia Areata.
SOLUTION:
Alopecia Areata, a surprisingly common condition, touches the lives of approximately 2% of individuals worldwide. Whether facing it, overcoming it, or poised to encounter it, a significant global community grapples with Alopecia Areata. In the United States, an astounding 6.7 million people are affected by this condition. Join the movement to raise awareness and support those affected by participating in the first campaign for the only FDA-approved treatment for Alopecia Areata.
Services:
Digital
Social
Retail
Digital
Social
Retail
Photography:
Lightfarm Studios
—
Industry:
Pharmaceuticals, Eli Lilly - HCP
Lightfarm Studios
—
Industry:
Pharmaceuticals, Eli Lilly - HCP
